Revance Therapeutics Inc (RVNC) Stock: A Comprehensive 52-Week Review
The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Revance Therapeutics Inc’s current trading price is -84.41% away from its 52-week high, while its distance from the 52-week low is 18.40%. The stock’s price range for this period has been between $5.00 and $37.98 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 1.7 million for the day, a number notably higher than the average daily volume of 1.64 million over the last three months. In terms of market performance, Revance Therapeutics